Literature DB >> 10716183

Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

R N Jorissen1, V C Epa, H R Treutlein, T P Garrett, C W Ward, A W Burgess.   

Abstract

The Epidermal Growth Factor (EGF) receptor is a tyrosine kinase that mediates the biological effects of ligands such as EGF and transforming growth factor alpha. An understanding of the molecular basis of its action has been hindered by a lack of structural and mutational data on the receptor. We have constructed comparative models of the four extracellular domains of the EGF receptor that are based on the structure of the first three domains of the insulin-like growth factor-1 (IGF-1) receptor. The first and third domains of the EGF receptor, L1 and L2, are right-handed beta helices. The second and fourth domains of the EGF receptor, S1 and S2, consist of the modules held together by disulfide bonds, which, except for the first module of the S1 domain, form rod-like structures. The arrangement of the L1 and S1 domains of the model are similar to that of the first two domains of the IGF-1 receptor, whereas that of the L2 and S2 domains appear to be significantly different. Using the EGF receptor model and limited information from the literature, we have proposed a number of regions that may be involved in the functioning of the receptor. In particular, the faces containing the large beta sheets in the L1 and L2 domains have been suggested to be involved with ligand binding of EGF to its receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716183      PMCID: PMC2144539          DOI: 10.1110/ps.9.2.310

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  71 in total

1.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

2.  Recognition of errors in three-dimensional structures of proteins.

Authors:  M J Sippl
Journal:  Proteins       Date:  1993-12

3.  A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.

Authors:  T Moriai; M S Kobrin; C Hope; L Speck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

4.  Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.

Authors:  M T Harte; L E Gentry
Journal:  Arch Biochem Biophys       Date:  1995-10-01       Impact factor: 4.013

5.  Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor.

Authors:  J H Naismith; T Q Devine; B J Brandhuber; S R Sprang
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

Review 6.  TGF-alpha and EGFR in head and neck cancer.

Authors:  J R Grandis; D J Tweardy
Journal:  J Cell Biochem Suppl       Date:  1993

7.  A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing.

Authors:  P Roach; Y Zick; P Formisano; D Accili; S I Taylor; P Gorden
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

Review 8.  Structure-function relationships for the EGF/TGF-alpha family of mitogens.

Authors:  L C Groenen; E C Nice; A W Burgess
Journal:  Growth Factors       Date:  1994       Impact factor: 2.511

Review 9.  Neu and its ligands: from an oncogene to neural factors.

Authors:  E Peles; Y Yarden
Journal:  Bioessays       Date:  1993-12       Impact factor: 4.345

10.  The Drosophila insulin receptor homolog: a gene essential for embryonic development encodes two receptor isoforms with different signaling potential.

Authors:  R Fernandez; D Tabarini; N Azpiazu; M Frasch; J Schlessinger
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.